What we invest in
We invest financial and intellectual capital in all stages of life science companies that take on the most prevalent and costly diseases facing major economies and health systems. We systematically apply our codified and proven methods of innovation management to support them to succeed with the highest levels of efficiency and purpose.
We are constantly looking for firms led by remarkable entrepreneurs; with exceptional technologies and products; addressing major global diseases; with potentially disruptive business models; and which can be grown to create significant revenues and thereby provide exceptional returns on investment and make a positive difference to population health and impact on the world.
Through our deal-making, strategic, and operational expertise, we bridge the gap between venture capital and private equity in the life sciences. Our current portfolio is comprised of biopharmaceutical and healthcare technology investments including new company formation and backing established firms with valuable assets.
Life Sciences Investments
Healthcare Technology Investments
The development of ever more efficient ways to generate reliable, valid, and actionable evidence drives value in the innovation life cycle. We have invested in, and partner with, companies that have some of the most advanced evidence generation tools available today: